Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 84.05
+0.27 (0.32%)
Sep 30, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 34.19 billion as of October 3, 2025. Its market cap has increased by 52.04% in one year.
Market Cap
34.19B
Enterprise Value
33.54B
Revenue
3.14B
Ranking
n/a
PE Ratio
36.10
Stock Price
84.05
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 34.19B, an increase of 138.10%. That is a compound annual growth rate of 16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 34.19B | 14.56% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 150.50B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |